Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by noodleyon Jul 16, 2010 4:38pm
443 Views
Post# 17275978

RE: The Site is Not Wrong ... It is just bad web d

RE: The Site is Not Wrong ... It is just bad web dthanks for the heads up, hunt.  and here's a thought.....maybe you should email sct (stem cell theatrics) and advise them to make sure folks are prepared to jump thru all the hoops you've discovered to actually read the bloody thing.  oh....and in the email...sct might want to further advise that unlike most websites....people will need an extra 20 minutes or so to figure our how to jump thru the hoops. the website - like their last couple of nr's...just stinks of little league attitude and somebody in a hurry.   can't wait till they put together a team that knows how to play hardball.
Bullboard Posts